Filing Flows › Consumer Discretionary › Regenerative Medical Technology Group (RMTG)
Regenerative Medical Technology Group (RMTG) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 19, 2026 · Regenerative Medical Technology Group (RMTG) Q2 2026 earnings results →
Q2 2026 Revenue up 309% year over year to $4.0M · 72¢ of every $1 of revenue lost · operating margin 14.1%
Regenerative Medical Technology Group made $4.0M in Q2 2026 (+309% Y/Y). Operating margin 14.1%, net loss $2.9M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 19, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $4.0M in Q2 2026, up 309% year over year and up 52% from the previous quarter.
Gross margin was 64.1%, up 4.5 points from Q2 2025. Operating profit was $566K, a 14.1% margin (up 39.5 points year over year). Operating expenses grew 141% against revenue growth of 309%. The fastest-growing cost line was Sales & marketing (+270%). The quarter ended with a net loss of $2.9M, wider than the previous quarter's $876K loss. Net interest and other expense of $3.5M was the main reason.
Operating cash flow was $332K. Non-cash charges added back $91K of depreciation and amortization. Working capital and other items added $3.1M. Capital expenditures of $43K left free cash flow of $288K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 19, 2026 | $4.0M | +309% | 14.1% | −$2.9M | $332K |
| Q1 2026 | 10-Q | Jun 9, 2026 | $2.6M | +94% | 8.7% | −$876K | $102K |
| Q4 2025 | 10-K | May 14, 2026 | $1.6M | +4% | -19.5% | −$1.4M | $38K |
| Q3 2025 | 10-Q | Nov 19, 2025 | $1.2M | +20% | -37.8% | −$4.4M | −$204K |
| Q2 2025 | 10-Q | Aug 19, 2025 | $983K | +24% | -25.4% | −$1.3M | −$598K |
| Q1 2025 | 10-Q | May 20, 2025 | $1.4M | +67% | 9.9% | −$760K | $57K |
| Q4 2024 | 10-K | Apr 15, 2025 | $1.5M | +145% | 25.2% | −$638K | $379K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Regenerative Medical Technology Group
Regenerative Medical Technology Group Inc. (the “Company”) was originally organized under the laws of Washington State in 1999, as Spectrum Ventures, LLC to develop market and sell VOIP (Voice over Internet Protocol) services. In 2002, the Company changed its name to Nxtech Wireless Cable Systems, Inc. In August 2007, the Company changed its name to Oriens Travel & Hotel Management Corp. In November 2014, the Company changed its name to Pure Hospitality Solutions, Inc. On November 16, 2016 , the Company entered into an Agreement and Plan of Merger between the Company and Meso Numismatics Corp. (“Meso”), a Florida corporation. The acquisition of Meso was to support the Company’s overall mission of specializing in ventures related to Central America and the Latin countries of the Caribbean; not limited to tourism.
In its own words, from its 10-Q, filed Aug 19, 2026.
Regenerative Medical Technology Group against its Retail-Retail Stores, NEC peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +309% against the peers' median 0%. Operating margin: 14.1% against the peers' median 9.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| RMTG Regenerative Medical Technology Group | Q2 2026 | $4.0M | +309% | 14.1% |
| ULTA Ulta Beauty | Q2 FY27 | $3.0B | +9% | 12.5% |
| BBWI Bath & Body Works | Q2 FY27 | $1.5B | -2% | 14.3% |
| WOOF Petco Health & Wellness Company | Q2 FY27 | $1.5B | 0% | 3.2% |
| SBH Sally Beauty Holdings | Q3 FY26 | $935M | +0.2% | 9.2% |
| TITN Titan Machinery | Q2 FY27 | $496M | -9% | -0.5% |
| LESL Leslie's | Q3 FY26 | $458M | -8% | 13.4% |
| SGU Star Group, L.P. | Q3 FY26 | $358M | +17% | -9.5% |
| FLWS 1 800 Flowers | Q1 FY27 | $171M | -11% | -27.1% |
Source: Regenerative Medical Technology Group 10-Q on SEC EDGAR · CIK 1760026 · Retail-Retail Stores, NEC
More on RMTG
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results